Related Experiment Video
Updated: May 23, 2025
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Beneficial and challenges of exosome application in ischemic heart disease
Narges Mardi1, Parisa Khanicheragh2, Zahra Abbasi-Malati3,4
1Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Insights
Exosomes (Exos), derived from stem cells, show significant potential for treating ischemic heart diseases (IHD). These extracellular vesicles (EVs) offer promising regenerative mechanisms for cardiovascular repair.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Biomedical Engineering
Background:
- Cardiovascular diseases (CVDs) are a leading cause of mortality and morbidity.
- Myocardial infarction (MI), a critical CVD, results from interrupted blood supply to the heart.
- Stem cells offer therapeutic potential for tissue injury via differentiation and factor release.
Purpose of the Study:
- To review the role of exosomes (Exos) in treating ischemic heart diseases (IHD).
- To elucidate the regenerative mechanisms of Exos in the context of IHD.
- To highlight the theranostic potential of Exos in cardiovascular medicine.
Main Methods:
- Literature review of pre-clinical and clinical studies on Exos in IHD.
- Analysis of stem cell-derived Exos and their therapeutic actions.
- Focus on the molecular and cellular mechanisms of Exos-mediated repair.
Main Results:
- Exosomes (Exos) are extracellular vesicles (EVs) with significant theranostic applications.
- Exos derived from stem cells demonstrate potent regenerative capabilities for cardiac tissue.
- Pre-clinical and clinical studies support the use of Exos in managing IHD.
Conclusions:
- Exosomes represent a promising cell-free therapeutic strategy for IHD.
- Understanding Exos mechanisms is crucial for advancing cardiovascular regenerative therapies.
- Exos offer a viable alternative or adjunct to traditional stem cell therapies for heart repair.
Abstract:
Cardiovascular diseases are the main cause of death and disability in the clinical setting. Among several pathological conditions, myocardial infarction (MI) is a common clinical finding and happens due to the reduction or complete interruption of blood support. Stem cells and progenitors are valid cell sources with significant potential to alleviate several tissue injuries. Differentiation to mature and functional cells and the release of various growth factors, and cytokines are the main reparative mechanisms by which stem cells mediate their reparative tasks. Exosomes (Exos), a subset of extracellular vesicles (EVs), exhibit great theranostic potential in biomedicine. Along with whole-cell-based therapies, the pre-clinical and clinical application of Exos has been extended in animals and humans with ischemic heart diseases (IHD). Here, in this review article, we aimed to highlight the importance of Exos in IHD and address the mechanism of action by focusing on their regenerative potential.
Related Concept Videos
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...